Skip to content

Prognosis Study of Renal Transplantation in Children

A Study for Predicting the Prognosis of Renal Transplantation by the Clear Pathogenic Gene of End-stage Renal Disease in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03708094
Enrollment
184
Registered
2018-10-17
Start date
2018-11-01
Completion date
2021-12-30
Last updated
2022-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure

Keywords

prognosis, pathogenic gene, decision tree study

Brief summary

Kidney transplantation is the worldwide recognized best renal replacement treatment for children with end-stage renal disease. Successful kidney transplantation can not only alleviate uremia symptoms, improve survival and quality of life, but also achieve optimal growth and cognitive development in children. Clarifying the cause of end-stage renal disease before transplantation is of vital importance to the comprehensive assessment and follow-up of the extra renal organs, reducing the risk of recurrence of the primary disease, the choice of the timing and the mode of transplantation, the scheme of immunosuppressive agents, as well as providing accurate genetic counseling for families. Timely molecular diagnosis and correct data analysis play a positive role in promoting the etiological diagnosis of uremic children before renal transplantation. We hypothesized that identifying the molecular diagnosis can improve prognosis of kidney transplantation. 300 cases of end-stage renal disease children were included and whole exome sequencing are performed to identify the molecular diagnosis. The cohort was divided into 2 groups according to whether the molecular diagnosis was clear. Clinical information before and after renal transplantation of each group are collected, and the decision tree analysis model and logistic regression model are used to study the effect of clear molecular diagnosis on the 3 year survival rate of renal transplantation.

Interventions

DIAGNOSTIC_TESTmolecular diagnosis

whole exome sequencing and data analysis to elucidating molecular diagnosis

Sponsors

Boston Children's Hospital
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
Central South University
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Donors and recipients who accepted kidney transplantation at centers included in this study

Exclusion criteria

* Older than 18 years old. * There are severe systemic diseases and/or local and/or spiritual system diseases. * There are systemic acute or chronic infections, infectious diseases. * The donated organ dysfunction, or other causes that are damage to donors and recipients.

Design outcomes

Primary

MeasureTime frameDescription
Renal graft survival rate3 years after renal transplantationThe number of survival renal transplant graft in the 3 year observation period accounted for the percentage of the total cases studied.

Secondary

MeasureTime frameDescription
Incidence of acute rejection3 years after renal transplantationThe number of acute rejection after transplantation during the 3 year observation period accounted for the percentage of the total cases studied.
Recurrence rate of primary disease3 years after renal transplantationThe number of patient with primary disease recurrence during the 3 year observation period accounted for the percentage of the total cases studied.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026